3 August 2020
Russell has heard from many members with concerns for at-risk and vulnerable children in this period, and we're now seeking your insights. He also welcomes the UK government's recent announcement about obesity and junk food advertising, but we need to understand how people's lives are and see the de...
26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
7 April 2020
Dr Susan Broster has been appointed as our Global Officer, working closely with the staff team and many clinical volunteers to deliver our global child health programmes. Sue replaces Dr Bhanu Williams, who now joins our Board of Trustees.
6 April 2020
Growing up overweight or obese is a pervasive and—importantly—preventable disadvantage. It worsens physical and mental health and reduces social and economic success. It can trap people in a cycle of sedentary activity, overeating, and escalating weight. This leads to poor wellbeing and, ultimately,...
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
13 March 2020
Russell updates members on how the College is responding to COVID-19. In this message, which has been emailed to all members, he outlines the College's actions towards COVID-19 and highlights advice and guidance for our members.
4 March 2020
The RCPCH has today published State of Child Health 2020, the largest ever compilation of data on the health of babies, children and young people across all four UK nations. The report shows that for many measures of children’s health and wellbeing, progress has stalled, or is in reverse – something...
2 March 2020
The Medicines and Healthcare products Regulatory Agency (MHRA) is requesting that healthcare professionals report any suspected side effects or safety concerns with e-cigarettes and the e-liquids used for vaping to the Yellow Card Scheme.
19 February 2020
Russell has been speaking with quite a few members about COVID-19, also known as the novel coronavirus. In this message, which has been emailed to all members, he outlines what we know and how the situation is affecting the RCPCH.
5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.